Maybe she’s born with it, maybe it’s … genetic optimization?

Prospective parents using in vitro fertilization (IVF) will soon be able to select embryos based on their potential risk for diseases — including illnesses that develop later in life — thanks to a groundbreaking $5,999 service announced this week by a US biotech company.

“Before there’s a heartbeat, there’s DNA,” Kian Sadeghi, founder and chief executive of Nucleus Genomics , said in a statement . “One file containing DNA and genetic markers can tell you more about your baby’s future than any other test a doctor could possibly run at this stage.” 4

What is IVF?

The popular fertility treatment involves removing eggs from a woman’s ovaries and fertilizing them with sperm in a lab.

The resulting embryo — which could

See Full Page